LifeScience Emerging Biotech
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, announced that it has entered into a strategic collaboration agreement with AstraZeneca (...
July 03, 2026 | News
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer...
July 01, 2026 | News
CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the "MCV4",...
July 01, 2026 | News
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies ATLATL Innovation Center ("A...
June 26, 2026 | News
The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavem...
June 23, 2026 | News
Non-dilutive funding will support the commercialization, development, and expansion strategy for Sonire's Ultrasound-Guided HIFU Platform Sonire Therapeut...
June 19, 2026 | News
Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory stu...
June 15, 2026 | News
SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...
June 11, 2026 | News
Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently...
June 08, 2026 | News
LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developi...
May 19, 2026 | News
As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 r...
May 15, 2026 | News
Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) announced the achievement of a further milestone. This marks the th...
May 08, 2026 | News
Telix and Regeneron to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model. Collabora...
April 14, 2026 | News
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...
April 13, 2026 | News
Most Read
Bio Jobs
News
Editor Picks